SCHEMBL27487952

SCHEMBL27487952

O=CC(=O)c1cnc2cc([N+](=O)[O-])cc(Br)c2n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NQO2 P16083 1/20 0.50
▸ LCK P06239 1/20 0.41
▸ MAPT P10636 6/20 0.37
▸ ALDH1A1 P00352 5/20 0.37
▸ HTT P42858 4/20 0.37
▸ LMNA P02545 1/20 0.37
▸ TDP1 Q9NUW8 3/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ PKM P14618 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ NFKB1 P19838 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ CASP6 P55212 1/20 0.35
▸ NFKB2 Q00653 1/20 0.35
▸ RELA Q04206 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27453910 0.85 TXNRD1 (0.44) MAPTALDH1A1HTTTDP1KDM4E
SCHEMBL27503692 0.84 ALDH1A1 (0.40) NQO2MAPTALDH1A1HTTLMNA
SCHEMBL27480411 0.73 POLB (0.45) MAPTALDH1A1HTTLMNATDP1
SCHEMBL25219845 0.70 NQO2 (0.55) NQO2LCKMAPTALDH1A1HTT
SCHEMBL5756956 0.66 NQO2 (0.50) NQO2LCKMAPTALDH1A1HTT
SCHEMBL28322665 0.66 GRIA1 (0.56) MAPTALDH1A1HTTLMNATDP1
SCHEMBL27547765 0.66 NQO2 (0.36) NQO2MAPTALDH1A1LMNAKDM4E
SCHEMBL1361650 0.65 NQO2 (0.49) NQO2MAPTALDH1A1HTTTDP1
SCHEMBL8087024 0.65 NQO2 (0.60) NQO2MAPTALDH1A1HTTLMNA
SCHEMBL27449490 0.65 NQO2 (0.31) NQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1193968-A 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives NOVARTIS AG (CH) 1998-09-23 — — CN disclosed
Send feedback